These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38523398)

  • 61. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
    Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
    Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
    Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations.
    Grandhi A; Boros AL; Berardo N; Reich RF; Freedman PD
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):e41-7. PubMed ID: 22940020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
    Oschlies I; Lisfeld J; Lamant L; Nakazawa A; d'Amore ES; Hansson U; Hebeda K; Simonitsch-Klupp I; Maldyk J; Müllauer L; Tinguely M; Stücker M; Ledeley MC; Siebert R; Reiter A; Brugières L; Klapper W; Woessmann W
    Haematologica; 2013 Jan; 98(1):50-6. PubMed ID: 22773605
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
    Jaye DL; Feldman AL
    Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
    [No Abstract]   [Full Text] [Related]  

  • 66. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
    Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
    Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.
    Merkel O; Hamacher F; Laimer D; Sifft E; Trajanoski Z; Scheideler M; Egger G; Hassler MR; Thallinger C; Schmatz A; Turner SD; Greil R; Kenner L
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16228-33. PubMed ID: 20805506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
    Merkel O; Hamacher F; Griessl R; Grabner L; Schiefer AI; Prutsch N; Baer C; Egger G; Schlederer M; Krenn PW; Hartmann TN; Simonitsch-Klupp I; Plass C; Staber PB; Moriggl R; Turner SD; Greil R; Kenner L
    J Pathol; 2015 Aug; 236(4):445-56. PubMed ID: 25820993
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Primary Leptomeningeal Lymphoma: Clinicopathologic Features of 2 Rare Phenotypes.
    Vizcaino MA; Giannini C; King RL; Johnson DR; Yang T; Raghunathan A
    J Neuropathol Exp Neurol; 2022 Nov; 81(12):1002-1007. PubMed ID: 36102830
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Leukemic presentation of a highly aggressive ALK-negative anaplastic large cell lymphoma.
    Xu D; Naresh KN
    Blood; 2021 Sep; 138(13):1198. PubMed ID: 34591095
    [No Abstract]   [Full Text] [Related]  

  • 71. Primary central nervous system ALK-positive anaplastic large cell lymphoma with CD56 abnormally expression in a Chinese child: Challenge in diagnostic practice.
    Liu Q; Chen X; Li G; Ye Y; Liu W; Zhao S; Zhang W
    Int J Immunopathol Pharmacol; 2020; 34():2058738420941756. PubMed ID: 32664812
    [TBL] [Abstract][Full Text] [Related]  

  • 72. De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells.
    Babin L; Darchen A; Robert E; Aid Z; Borry R; Soudais C; Piganeau M; De Cian A; Giovannangeli C; Bawa O; Rigaud C; Scoazec JY; Couronné L; Veleanu L; Cieslak A; Asnafi V; Sibon D; Lamant L; Meggetto F; Mercher T; Brunet E
    Mol Cancer; 2022 Mar; 21(1):65. PubMed ID: 35246138
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.
    Letovanec I; Finn S; Zygoura P; Smyth P; Soltermann A; Bubendorf L; Speel EJ; Marchetti A; Nonaka D; Monkhorst K; Hager H; Martorell M; Sejda A; Cheney R; Hernandez-Losa J; Verbeken E; Weder W; Savic S; Di Lorito A; Navarro A; Felip E; Warth A; Baas P; Meldgaard P; Blackhall F; Dingemans AM; Dienemann H; Dziadziuszko R; Vansteenkiste J; O'Brien C; Geiger T; Sherlock J; Schageman J; Dafni U; Kammler R; Kerr K; Thunnissen E; Stahel R; Peters S;
    J Thorac Oncol; 2018 Mar; 13(3):413-425. PubMed ID: 29191776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.
    Boi M; Todaro M; Vurchio V; Yang SN; Moon J; Kwee I; Rinaldi A; Pan H; Crescenzo R; Cheng M; Cerchietti L; Elemento O; Riveiro ME; Cvitkovic E; Bertoni F; Inghirami G;
    Oncotarget; 2016 Nov; 7(48):79637-79653. PubMed ID: 27793034
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.
    Molavi O; Samadi N; Wu C; Lavasanifar A; Lai R
    Leuk Lymphoma; 2016 May; 57(5):1154-62. PubMed ID: 26133723
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Leukemic presentation of ALK-negative anaplastic large cell lymphoma in a patient with myelodysplastic syndrome.
    Tanaka H; Ohwada C; Hashimoto S; Sakai S; Takeda Y; Abe D; Takagi T; Ohshima K; Nakaseko C
    Intern Med; 2012; 51(2):199-203. PubMed ID: 22246491
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature.
    Miranda RN; Lin L; Talwalkar SS; Manning JT; Medeiros LJ
    Arch Pathol Lab Med; 2009 Sep; 133(9):1383-90. PubMed ID: 19722744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary central nervous system ALK positive anaplastic large cell lymphoma with predominantly leptomeningeal involvement in an adult.
    Park JS; Park H; Park S; Kim SJ; Seol HJ; Ko YH
    Yonsei Med J; 2013 May; 54(3):791-6. PubMed ID: 23549832
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnosis of the leukemic phase of ALK-positive anaplastic large cell lymphoma by immunohistochemistry on cell block prepared from peripheral blood buffy coat.
    Kundoo A; Sethy M; Sable MN; Mishra P; Panigrahi A; Adhya AK
    Indian J Pathol Microbiol; 2020; 63(4):642-644. PubMed ID: 33154326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.